Literature DB >> 26155736

Association of TCF7L2 Polymorphism with Diabetic Nephropathy in the South Indian Population.

Dhanasekaran Bodhini1, Manickam Chidambaram1,2, Samuel Liju1, Visvanathan G Prakash1, Vijay Gayathri1, Coimbatore S Shanthirani1, Unnikrishnan Ranjith3, Ranjit M Anjana1,3, Viswanathan Mohan1,3, Venkatesan Radha1.   

Abstract

The transcription factor 7-like 2 (TCF7L2) gene plays a significant role in the development of type 2 diabetes and diabetic nephropathy. The aim of this study was to investigate the association of TCF7L2 rs12255372 (G/T)polymorphism with type 2 diabetic nephropathy in the South Indian population. A total of 2102 subjects, 927 normal glucose tolerant (NGT) subjects, 598 type 2 diabetic subjects without nephropathy (DM), and 577 type 2 diabetic subjects with nephropathy (DN) were genotyped by MassARRAY. As compared to the NGT group, the odds ratio (adjusted for age, sex, BMI, HbA1c, and systolic BP) computed for the GT/TT genotype taking the GG genotype as reference was found to be 2.02 (95% CI: 1.16-3.51, p = 0.013) for DN and 1.94 (95% CI: 1.36-2.78, p = 0.0002) for DM. The genotype frequency was not significantly different between the DM and DN groups. In conclusion, the rs12255372 polymorphism in the TCF7L2 gene is associated with type 2 diabetes and DN but its association with DN is mediated through diabetes.
© 2015 John Wiley & Sons Ltd/University College London.

Entities:  

Keywords:  TCF7L2 gene; diabetic nephropathy; rs12255372 variant; south Indians; type 2 diabetes

Year:  2015        PMID: 26155736     DOI: 10.1111/ahg.12122

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  3 in total

1.  Role of TCF7L2 and PPARG2 Gene Polymorphisms in Renal and Cardiovascular Complications among Patients with Type 2 Diabetes: A Cohort Study.

Authors:  Bancha Satirapoj; Pamila Tasanavipas; Ouppatham Supasyndh
Journal:  Kidney Dis (Basel)       Date:  2019-03-06

2.  Association of the Transcription Factor 7 Like 2 (TCF7L2) Polymorphism With Diabetic Nephropathy Risk: A Meta-Analysis.

Authors:  Zhenqian Fan; Qiliang Cai; Yu Chen; Xuying Meng; Fenglin Cao; Shaoxiong Zheng; Jianchao Guo
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

3.  Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism.

Authors:  Gisela Geoghegan; Judith Simcox; Marcus M Seldin; Timothy J Parnell; Chris Stubben; Steven Just; Lori Begaye; Aldons J Lusis; Claudio J Villanueva
Journal:  Mol Metab       Date:  2019-03-14       Impact factor: 7.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.